Today marks an exciting milestone for Cerno Health as we formally sign an agreement with Carbon Medical to become their Master Distributor for the Carbon Fusion Biopsy System in the UK.

The Carbon Medical Device VENUS platform brings a new level of intelligence to MRI–Ultrasound fusion prostate biopsy and PCNL navigation, powered by advanced AI-driven automation.

What makes this system unique is its next-generation AI algorithms, which can automatically identify and contour the prostate — removing the need for manual segmentation by a radiologist and dramatically streamlining the workflow for clinicians.

This means:

• Faster procedure planning
• Greater consistency and accuracy
• Wider accessibility of fusion biopsy technology

We believe this platform will play an important role in expanding access to precision diagnostics for prostate and kidney procedures worldwide.

You’ll be able to see the VENUS Fusion System in action at BAUS & BAUN 2026, where the Cerno Health team will be demonstrating the technology and its AI capabilities.